Evidence map›Paper›PMID 3110347›Full record

ArticleThe Journal of experimental medicine1987

Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.

W F Owen, M E Rothenberg, D S Silberstein, J C Gasson, R L Stevens, K F Austen, R J Soberman

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1987. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
20.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 394 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Effects of Asian Dust Particles on the Early-Stage Antigen-Induced Immune Response of Asthma in NC/Nga Mice.International journal of environmental research and public health · 2016
    Article
  6. Article
  7. Article
  8. Cysteinyl leukotrienes and their receptors; emerging concepts.Allergy, asthma & immunology research · 2014
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cytokines in asthma.Thorax · 1999
    Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

W F Owen
M E Rothenberg
D S Silberstein
J C Gasson
R L Stevens
K F Austen
R J Soberman
Brigham and Women's Hospital · USGGD Amsterdam · NL

Funding

THE MAST CELLSP50AI023401 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI STEVENS, RICHARD L · 1985 to 1990
–
IN VITRO STUDIES OF THE MECHANISM OF ANAPHYLAXISR01AI022531 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI AUSTEN, K. FRANK · 1985 to 1989
–
BIOSYNTHESIS, BIOLOGY &METABOLISM OF THE LEUKOTRIENESR01AI022563 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI SOBERMAN, ROY · 1985 to 1992
–
IN VITRO STUDIES OF THE MECHANISM OF ANAPHYLAXISR37AI022531 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI AUSTEN, K. FRANK · 1990 to 1999
–
NIAID NIH HHS AI-22531NIAID NIH HHS AI-22563NIAID NIH HHS AI-23401
6 · The paper itself

Abstract

Normodense human peripheral blood eosinophils were isolated under sterile conditions from the 22/23 and 23/24% interfaces and the cell pellet of metrizamide gradients. After culture for 7 d in RPMI media in the presence of 50 pM biosynthetic (recombinant) human granulocyte/macrophage colony-stimulating factor (rH GM-CSF), 43 +/- 7% (mean +/- SEM, n = 8) of the cells were viable; in the absence of rH GM-CSF, no eosinophils survived. The rH GM-CSF-mediated viability was concentration dependent; increased survival began at a concentration of 1 pM, a 50% maximal response was attained at approximately 3 pM, and a maximal effect was reached at concentrations of greater than or equal to 10 pM rH GM-CSF. In the presence of rH GM-CSF and mouse 3T3 fibroblasts, 67 +/- 6% (mean +/- SEM, n = 8) of the eosinophils survived for 7 d. In a comparative analysis, there was no difference in eosinophil viability after 7 and 14 d (n = 3) in the presence of 50 pM GM-CSF and fibroblasts. Culture with fibroblasts alone did not support eosinophil survival. The addition of fibroblast-conditioned media to rH GM-CSF did not further improve eosinophil viability, indicating a primary role for GM-CSF in supporting these eosinophil cell suspensions ex vivo and a supplementary role for 3T3 fibroblasts. Eosinophils cultured for 7 d localized on density gradient sedimentation at the medium/18, 18/20, and 20/21 interfaces of metrizamide gradients, indicating a change to the hypodense phenotype from their original normodense condition. In addition, the cultured eosinophils generated approximately 2.5-fold more LTC4 than freshly isolated cells when stimulated with the calcium ionophore A23187 and manifested sevenfold greater antibody-dependent killing of S. mansoni larvae than the freshly isolated, normodense cells from the same donor. Thus we demonstrate the rH GM-CSF dependent conversion in vitro of normodense human eosinophils to hypodense cells possessing the augmented biochemical and biological properties characteristic of the hypodense eosinophils associated with a variety of hypereosinophilic syndromes. In addition, these studies provide a culture model of at least 14 d suitable for the further characterization of hypodense eosinophils.

Indexed as

AnimalsAntibody-Dependent Cell CytotoxicityCalcimycinCell CountCells, CulturedCell SurvivalCentrifugation, Density GradientEosinophilsFibroblastsHumansInterleukin-3MiceNeutrophilsRecombinant ProteinsSchistosoma mansoniSRS-ACalcimycinInterleukin-3Recombinant ProteinsSRS-A

Identifiers

PMID3110347
PMCPMC2188636
OpenAlexW2011658825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.